Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
32.24
+0.10 (0.31%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Veracyte Market Cap

Veracyte has a market cap or net worth of $2.51 billion as of April 25, 2025. Its market cap has increased by 56.16% in one year.

Market Cap
2.51B
Enterprise Value
2.27B
1-Year Change
56.16%
Ranking
Category
Stock Price
$32.24

Market Cap Chart

Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $2.51B, an increase of 816.51%. That is a compound annual growth rate of 21.26%.

History

DateMarket Cap% Change
Apr 24, 20252.51B-18.37%
Dec 31, 20243.07B52.74%
Dec 29, 20232.01B18.01%
Dec 30, 20221.70B-41.83%
Dec 31, 20212.93B3.30%
Dec 31, 20202.83B107.80%
Dec 31, 20191.36B167.37%
Dec 31, 2018510.00M129.42%
Dec 29, 2017222.30M2.77%
Dec 30, 2016216.30M8.58%
Dec 31, 2015199.20M-8.37%
Dec 31, 2014217.40M-28.72%
Dec 31, 2013305.00M11.27%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 736.58B
UnitedHealth Group 395.06B
Johnson & Johnson 373.95B
AbbVie 310.63B
Novo Nordisk 266.18B
Abbott Laboratories 224.04B
Novartis AG 211.63B
AstraZeneca 210.34B
Market Cap Rankings